CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65
© 2021 The Authors. Published under the terms of the CC BY 4.0 license..
The E3 ubiquitin ligase complex CDC20-activated anaphase-promoting complex/Cyclosome (APC/CCDC20 ) plays a critical role in governing mitotic progression by targeting key cell cycle regulators for degradation. Cell division cycle protein 20 homolog (CDC20), the co-activator of APC/C, is required for full ubiquitin ligase activity. In addition to its well-known cell cycle-related functions, we demonstrate that CDC20 plays an essential role in osteogenic commitment of bone marrow mesenchymal stromal/stem cells (BMSCs). Cdc20 conditional knockout mice exhibit decreased bone formation and impaired bone regeneration after injury. Mechanistically, we discovered a functional interaction between the WD40 domain of CDC20 and the DNA-binding domain of p65. Moreover, CDC20 promotes the ubiquitination and degradation of p65 in an APC11-dependent manner. More importantly, knockdown of p65 rescues the bone loss in Cdc20 conditional knockout mice. Our current work reveals a cell cycle-independent function of CDC20, establishes APC11CDC20 as a pivotal regulator for bone formation by governing the ubiquitination and degradation of p65, and may pave the way for treatment of bone-related diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
EMBO reports - 22(2021), 9 vom: 06. Sept., Seite e52576 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Du, Yangge [VerfasserIn] |
---|
Links: |
---|
Themen: |
APC/C |
---|
Anmerkungen: |
Date Completed 22.10.2021 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.15252/embr.202152576 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329266063 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329266063 | ||
003 | DE-627 | ||
005 | 20231225204736.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.15252/embr.202152576 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329266063 | ||
035 | |a (NLM)34382737 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Du, Yangge |e verfasserin |4 aut | |
245 | 1 | 0 | |a CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.10.2021 | ||
500 | |a Date Revised 31.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 The Authors. Published under the terms of the CC BY 4.0 license. | ||
520 | |a The E3 ubiquitin ligase complex CDC20-activated anaphase-promoting complex/Cyclosome (APC/CCDC20 ) plays a critical role in governing mitotic progression by targeting key cell cycle regulators for degradation. Cell division cycle protein 20 homolog (CDC20), the co-activator of APC/C, is required for full ubiquitin ligase activity. In addition to its well-known cell cycle-related functions, we demonstrate that CDC20 plays an essential role in osteogenic commitment of bone marrow mesenchymal stromal/stem cells (BMSCs). Cdc20 conditional knockout mice exhibit decreased bone formation and impaired bone regeneration after injury. Mechanistically, we discovered a functional interaction between the WD40 domain of CDC20 and the DNA-binding domain of p65. Moreover, CDC20 promotes the ubiquitination and degradation of p65 in an APC11-dependent manner. More importantly, knockdown of p65 rescues the bone loss in Cdc20 conditional knockout mice. Our current work reveals a cell cycle-independent function of CDC20, establishes APC11CDC20 as a pivotal regulator for bone formation by governing the ubiquitination and degradation of p65, and may pave the way for treatment of bone-related diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a APC/C | |
650 | 4 | |a BMSCs | |
650 | 4 | |a CDC20 | |
650 | 4 | |a osteogenic differentiation | |
650 | 4 | |a p65 | |
650 | 7 | |a Cdc20 Proteins |2 NLM | |
650 | 7 | |a Cdc20 protein, mouse |2 NLM | |
650 | 7 | |a Cell Cycle Proteins |2 NLM | |
650 | 7 | |a Anaphase-Promoting Complex-Cyclosome |2 NLM | |
650 | 7 | |a EC 2.3.2.27 |2 NLM | |
700 | 1 | |a Zhang, Min |e verfasserin |4 aut | |
700 | 1 | |a Liu, Xuejiao |e verfasserin |4 aut | |
700 | 1 | |a Li, Zheng |e verfasserin |4 aut | |
700 | 1 | |a Hu, Menglong |e verfasserin |4 aut | |
700 | 1 | |a Tian, Yueming |e verfasserin |4 aut | |
700 | 1 | |a Lv, Longwei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xiao |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yunsong |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Ping |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Yongsheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t EMBO reports |d 2000 |g 22(2021), 9 vom: 06. Sept., Seite e52576 |w (DE-627)NLM111633540 |x 1469-3178 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g number:9 |g day:06 |g month:09 |g pages:e52576 |
856 | 4 | 0 | |u http://dx.doi.org/10.15252/embr.202152576 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |e 9 |b 06 |c 09 |h e52576 |